Резултати

eNauka >  Results >  Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s disease
Title: Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s disease
Authors Jessen, Frank; ...; Stefanova, Elka D. ; ...; (broj koautora 52)
Issue Date: 2025
Publication: The journal of prevention of Alzheimer's disease
ISSN: 2274-5807 JPAD-Journal of Prevention of Alzheimers Disease Search Idenfier
Publisher: [New York] : Elsevier
Type: Other
Collation: vol. 12 br. 8 str. 100259
DOI: 10.1016/j.tjpad.2025.100259
WoS-ID: 001565649400001
Scopus-ID: 2-s2.0-105014549239
PMID: 40640062
PMCID: PMC12413728
URI: https://enauka.gov.rs/handle/123456789/1000171
URL: https://www.sciencedirect.com/science/article/pii/S227458072500202X?via%3Dihub
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
Mp. category will be shown later

1
PubMed CentralTM
Алт метрика
Dimensions
Unpaywall

Google ScholarTM

Резултати на еНаука су заштићени ауторским правима и сва права су задржана, осим ако није другачије назначено.